CRAMP analog having potent antibiotic activity without hemolytic activity

Area of Science:

• Antimicrobial peptide research
• Medicinal chemistry
• Biotechnology

Background:

• CRAMP-18 is a functional region of the mouse antibiotic peptide CRAMP.
• Existing antibiotic peptides often face challenges with resistance and side effects.
• Developing novel antimicrobial agents with broad-spectrum activity and reduced toxicity is crucial.

Purpose of the Study:

• To design and synthesize novel analogs of CRAMP-18.
• To evaluate the antibiotic, antifungal, and antitumor activities of these analogs.
• To assess the hemolytic activity of the synthesized peptide analogs.

Main Methods:

• Chemical synthesis of three CRAMP-18 analogs with specific amino acid substitutions (Leu or Lys).
• In vitro testing of antimicrobial activity against bacterial and fungal strains.
• Evaluation of cytotoxicity against tumor cell lines.
• Assessment of hemolytic activity on red blood cells.

Main Results:

• Leucine substitution at positions 1 and 8 ([L(1, 8)]-CRAMP-18) markedly enhanced antimicrobial and antitumor activities.
• This leucine substitution did not significantly increase hemolytic activity.
• Lysine substitutions ([K(2, 13)]-CRAMP-18 and [K(9, 16)]-CRAMP-18) showed a lesser impact on activity.

Conclusions:

• [L(1, 8)]-CRAMP-18 demonstrates potent broad-spectrum antimicrobial and antitumor properties with low hemolytic activity.
• This analog represents a promising candidate for the development of novel peptide-based therapeutics.
• Strategic amino acid substitution can optimize the efficacy and safety profile of antimicrobial peptides.